Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
crispr
3
×
boston blog main
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
editas medicine
fda
gilead sciences
indiana blog main
indiana top stories
jennifer doudna
life sciences
macrogenics
multiple myeloma
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
sanofi
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
akouos
alector
alkermes
allergan
alnylam pharmaceuticals
What
month
3
×
bio
crispr
roundup
acquisitions
announced
argument
arguments
begin
berkeley’s
biopharma
cas
ceo
charpentier
collabs
colleague
congress
congressional
court
covid
daniel
date
deal
december
doudna
editing
emmanuelle
executives
feng
feud
gene
gilead
gilead’s
group
head
help
institute
introduce
ipo
isn’t
Language
unset
Current search:
month
×
crispr
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More
@techcrunch.com
7 years ago
Oral arguments for who owns CRISPR-Cas9 starts next month
